Skip to main content
SpringerLink
Log in

Precocious Puberty

  • Chapter
  • First Online:
Pediatric Endocrinology

Abstract

Precocious puberty has been a focus of interest for both the pediatric endocrinologist and the primary pediatrician for many years. The development and application of GnRH agonist (GnRHa) therapy to treat central precocious puberty in the 1980s significantly changed our approach to this disorder. More recently, application of molecular biological techniques has provided us with a better understanding of the intricacies of the regulation of gonadotropin and sex-steroid production characteristic of normal pubertal development and provided us with the tools to elucidate the etiologies of previously uncharacterized disorders of precocious puberty.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 449.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Grumbach MM, Kaplan SL. Recent advances in the diagnosis and management of sexual precocity. Acta Paediatr Jpn. 1988;30(Suppl):155–75.

    PubMed  Google Scholar 

  2. Schwanzel-Fukuda M, et al. Migration of luteinizing hormone-releasing hormone (LHRH) neurons in early human embryos. J Comp Neurol. 1996;366:547–57.

    Article  CAS  PubMed  Google Scholar 

  3. Plant TM, et al. The arcuate nucleus and the control of gonadotropin and prolactin secretion in the female rhesus monkey (Macaca mulatta). Endocrinology. 1978;102(1):52–62.

    Article  CAS  PubMed  Google Scholar 

  4. Mueller PL, et al. Hormone ontogeny in the ovine fetus. IX. Luteinizing hormone and follicle-stimulating hormone response to luteinizing hormone-releasing factor in mid-and late gestation and in the neonate. Endocrinology. 1981;108(3):881–6.

    Article  CAS  PubMed  Google Scholar 

  5. Sklar CA, et al. Hormone ontogeny in the ovine fetus. VII. Circulating luteinizing hormone and follicle-stimulating hormone in mid-and late gestation. Endocrinology. 1981;108(3):874–80.

    Article  CAS  PubMed  Google Scholar 

  6. Winter JS, et al. Gonadotrophins and steroid hormones in the blood and urine of prepubertal girls and other primates. Clin Endocrinol Metab. 1978;7(3):513–30.

    Article  CAS  PubMed  Google Scholar 

  7. Zsarmovsky AH, Garcia-Segura TL, Horvath LM, Naftolin BF. Plasticity of the hypothalamic GABA system and their relationship with GnRH neurons during positive gonadotropin feedback in non-human primates in 82nd Annual Meeting of the Endocrine Society; 2000; Toronto, ON, Canada.

    Google Scholar 

  8. Zhang SJ, Jackson MB. GABA-activated chloride channels in secretory nerve endings. Science. 1993;259:531–4.

    Article  CAS  PubMed  Google Scholar 

  9. Terasawa EF, Fernandez DL. Neurobiological mechanisms of the onset of puberty in primates. Endocr Rev. 2001;22(1):111–51.

    CAS  PubMed  Google Scholar 

  10. Dhom G. The prepubertal and pubertal growth of the adrenal (adrenarche). Beitr Pathol. 1973;150(4):357–77.

    Article  CAS  PubMed  Google Scholar 

  11. Sklar CA, Kaplan SL, Grumbach MM. Evidence for dissociation between adrenarche and gonadarche: studies in patients with idiopathic precocious puberty, gonadal dysgenesis, isolated gonadotropin deficiency, and constitutionally delayed growth and adolescence. J Clin Endocrinol Metab. 1980;51(3):548–56.

    Article  CAS  PubMed  Google Scholar 

  12. James VHT. The endocrine function of the human adrenal cortex. Proceedings of the Serono Symposia, Vol. 18. London/New York: Academic; 1978. p. ix, 628.

    Google Scholar 

  13. Zhang LH, et al. Serine phosphorylation of human P450c 17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. Proc Natl Acad Sci U S A. 1995;92(23):10,619–23.

    Article  CAS  Google Scholar 

  14. Miller WL, Auchus RJ, Geller DH. The regulation of 17,20 lyase activity. Steroids. 1997;62(1):133–42.

    Article  CAS  PubMed  Google Scholar 

  15. Braunstein GD. Gynecomastia. N Engl J Med. 1993;328(7):490–5.

    Article  CAS  PubMed  Google Scholar 

  16. Herman-Giddens ME, et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics. 1997;99(4):505–12.

    Article  CAS  PubMed  Google Scholar 

  17. Kaplowitz PB, Slora EJ, Wasserman RC, Pedlow SE, Herman-Giddens ME. Earlier onset of puberty in girls: relation to increased body mass index and race. Pediatrics. 2001;108:347–53.

    Article  CAS  PubMed  Google Scholar 

  18. Biro FM, McMahon RP, Striegel-Moore R, Crawford PB, Obarzanek E, Morrison JA, Barton BA, Falkner F. Impact of timing of pubertal maturation on growth in black and white female adolescents: the National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr. 2001;138:636–43.

    Article  CAS  PubMed  Google Scholar 

  19. Kaplowitz PR, Oberfield SE. Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society. Pediatrics. 1999;104(4 Pt 1):936–41.

    Article  CAS  PubMed  Google Scholar 

  20. Rosenfield RL, Lipton RB, Drum ML. Thelarche, pubarche and menarche attainment in children with normal and elevated body mass index. Pediatrics. 2009;123:84–8.

    Article  PubMed  Google Scholar 

  21. Biro FM, Galvez MP, Greenspan LC, Succop PA, et al. Pubertal assessment method and baseline characteristics in a mixed longitudinal study of girls. Pediatrics. 2010;126:e583–90.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Susman EJ, Houts RM, Steinberg L, Belsky J, et al. Longitudinal development of secondary sexual characteristics in girls and boys between ages 9 ½ and 15 ½ years. Arch Pediatr Adolesc Med. 2010;164:166–73.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Fuqua J. Treatment and outcomes of precocious puberty: an update. J Clin Endocrinol Metab. 2013;98(6):2198–207.

    Article  CAS  PubMed  Google Scholar 

  24. Rosenfield RL, et al. Current age of onset of puberty [letter]. Pediatrics. 2000;106(3):622–3.

    Article  CAS  PubMed  Google Scholar 

  25. Kaplowitz P, Bloch C. Section on endocrinology, American Academy of Pediatrics. Evaluation and referral of children with signs of early puberty. Pediatrics. 2016;137(1):e20153732.

    Article  Google Scholar 

  26. Ibanez L, et al. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1993;76(6):1599–603.

    CAS  PubMed  Google Scholar 

  27. Ibanez L, et al. Girls diagnosed with premature pubarche show an exaggerated ovarian androgen synthesis from the early stages of puberty: evidence from gonadotropin-releasing hormone agonist testing. Fertil Steril. 1997;67(5):849–55.

    Article  CAS  PubMed  Google Scholar 

  28. Ibanez L, de Zegher F, Potau N. Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: from a complex constellation to a simple sequence of prenatal onset. J Endocrinol Invest. 1998;21(9):558–66.

    Article  CAS  PubMed  Google Scholar 

  29. Ibanez L, et al. Hyperinsulinaemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche. Diabetologia. 1998;41(9):1057–63.

    Article  CAS  PubMed  Google Scholar 

  30. Ibanez L, Potau N, De Zegher F. Endocrinology and metabolism after premature pubarche in girls. Acta Paediatr Suppl. 1999;88(33):73–7.

    CAS  PubMed  Google Scholar 

  31. Ibanez L, Potau N, de Zegher P. Recognition of a new association: reduced fetal growth, precocious pubarche, hyperinsulinism and ovarian dysfunction. Ann Endocrinol (Paris). 2000;61(2):141–2.

    CAS  Google Scholar 

  32. Volta C, et al. Isolated premature thelarche and thelarche variant clinical and auxological follow-up of 119 girls. J Endocrinol Invest. 1998;21(3):180–3.

    Article  CAS  PubMed  Google Scholar 

  33. Ilicki A, et al. Premature thelarche—natural history and sex hormone secretion in 68 girls. Acta Paediatr Scand. 1984;73(6):756–62.

    Article  CAS  PubMed  Google Scholar 

  34. Pasquino AM, et al. Progression of premature thelarche to central precocious puberty. J Pediatr. 1995;126(1):11–4.

    Article  CAS  PubMed  Google Scholar 

  35. Mills JL, et al. Premature thelarche. Natural history and etiologic investigation. Am J Dis Child. 1981;135(8):743–5.

    Article  CAS  PubMed  Google Scholar 

  36. Rosenfield RL. Normal and almost normal precocious variations in pubertal development premature pubarche and premature thelarche revisited. Horm Res. 1994;41(Suppl 2):7–13.

    Article  PubMed  Google Scholar 

  37. Jenner MR, et al. Hormonal changes in puberty. IV. Plasma estradiol, LH, and FSH in prepubertal children, pubertal females, and in precocious puberty, premature thelarche, hypogonadism, and in a child with a feminizing ovarian tumor. J Clin Endocrinol Metab. 1972;34(3):521–30.

    Article  CAS  PubMed  Google Scholar 

  38. Escobar ME, Rivarola MA, Bergada C. Plasma concentration of oestradiol-17beta in premature thelarche and in different types of sexual precocity. Acta Endocrinol. 1976;81(2):351–61.

    CAS  PubMed  Google Scholar 

  39. Colon I, et al. Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development [in process citation]. Environ Health Perspect. 2000;108(9):895–900.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Belgorosky A, Chaler E, Rivarola MA. High serum sex hormone-binding globulin (SHBG) in premature thelarche. Clin Endocrinol (Oxf). 1992;37(3):203–6.

    Article  CAS  Google Scholar 

  41. Pescovitz OH, et al. Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response 10 luteinizing hormone-releasing hormone. J Clin Endocrinol Metab. 1988;67(3):474–9.

    Article  CAS  PubMed  Google Scholar 

  42. Wang C, et al. Serum bioactive follicle-stimulating hormone levels in girls with precocious sexual development. J Clin Endocrinol Metab. 1990;70(3):615–9.

    Article  CAS  PubMed  Google Scholar 

  43. Verrotti A, et al. Premature thelarche: a long-term follow-up. Gynecol Endocrinol. 1996;10(4):241–7.

    Article  CAS  PubMed  Google Scholar 

  44. Aritaki S, et al. A comparison of patients with premature thelarche and idiopathic true precocious puberty in the initial stage of illness. Acta Paediatr Jpn. 1997;39(1):21–7.

    Article  CAS  PubMed  Google Scholar 

  45. Orley JN, Goblyos P. Modern imaging methods in paediatric breast examination. Ceska Gynekol. 1995;60(3):153–7.

    CAS  PubMed  Google Scholar 

  46. Salardi S, et al. Outcome of premature thelarche: relation to puberty and final height. Arch Dis Child. 1998;79(2):173–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Palmert MR, Malin HV, Boepple PA. Unsustained or slowly progressive puberty in young girls: initial presentation and long-term follow-up of 20 untreated patients. J Clin Endocrinol Metab. 1999;84(2):415–23.

    CAS  PubMed  Google Scholar 

  48. Ibanez L, et al. Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab. 1998;83(10):3558–62.

    Article  CAS  PubMed  Google Scholar 

  49. Francois I, de Zegher F. Adrenarche and fetal growth. Pediatr Res. 1997;41:440–2.

    Article  CAS  PubMed  Google Scholar 

  50. Ibanez L, Potau N, de Zegher F. Precocious pubarche, dyslipidemia, and low IGF binding protein-1 in girls: relation to reduced prenatal growth. Pediatr Res. 1999;46(3):320–2.

    Article  CAS  PubMed  Google Scholar 

  51. Barker DJ, Hales CN, Fall CH, et al. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidemia (syndrome X): relation to reduced fetal growth. Diabetologia. 1993;36:62–7.

    Article  CAS  PubMed  Google Scholar 

  52. Hawkins LA, Chasalow FL, Blethen SL. The role of adrenocorticotropin testing in evaluating girls with premature adrenarche and hirsutism/oligomenorrhea. J Clin Endocrinol Metab. 1992;74:248–53.

    CAS  PubMed  Google Scholar 

  53. Speiser PW, Dupont B, Rubenstein P, Piazza A, Kastelan A, New MI. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet. 1985;37:650–67.

    CAS  PubMed  PubMed Central  Google Scholar 

  54. Likitmaskul SC, Cowell CT, Donaghue K, et al. Exaggerated adrenarche in children presenting with premature adrenarche. Clin Endocrinol (Oxf). 1995;42:265–72.

    Article  CAS  Google Scholar 

  55. Temeck JW, et al. Genetic defects of steroidogenesis in premature pubarche. J Clin Endocrinol Metab. 1987;64(3):609–17.

    Article  CAS  PubMed  Google Scholar 

  56. Sizonenko PC, Paunier L. Hormonal changes in puberty III: correlation of plasma dehydroepiandrosterone, testosterone, FSI-I, and LH with stages of puberty and bone age in normal boys and girls and in patients with Addison’s disease or hypogonadism or with premature or late adrenarche. J Clin Endocrinol Metab. 1975;41(5):894–904.

    Article  CAS  PubMed  Google Scholar 

  57. Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med. 1996;29:617–23.

    Article  Google Scholar 

  58. Moghetti P, Castello R, Negri C, et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab. 2000;85:139–46.

    CAS  PubMed  Google Scholar 

  59. Ibanez L, Valls C, Potua N, Marcos MV, de Zegher F. Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche. J Clin Endocrinol Metab. 2000;85:3526–30.

    CAS  PubMed  Google Scholar 

  60. Geller DH, Pacaud D, Gordon CM, Misra M, of the Drug and Therapeutics Committee of the Pediatric Endocrine Society. State of the art review: emerging therapies: the use of insulin sensitizers in the treatment of adolescents with polycystic ovary syndrome (PCOS). Int J Pediatri Endocrinol. 2011;2011:9.

    Article  CAS  Google Scholar 

  61. Pescovitz OH, et al. The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy. J Pediatr. 1986;108(1):47–54.

    Article  CAS  PubMed  Google Scholar 

  62. Robben SG, et al. Idiopathic isosexual central precocious puberty: magnetic resonance findings in 30 patients. Br J Radiol. 1995;68(805):34–8.

    Article  CAS  PubMed  Google Scholar 

  63. Bessa DS, Macedo DB, Brito VN, França MM, et al. High frequency of MKRN3 mutations in male central precocious puberty previously classified as idiopathic. Neuroendocrinology. 2017;105(1):17–25.

    Article  CAS  PubMed  Google Scholar 

  64. Dimitrova-Mladenova MS, Stefanova EM, Glushkova M, Todorova AP, Todorov T, Konstantinova MM, Kazakova K, Tincheva RS. Males with paternally inherited MKRN3 mutations may be asymptomatic. J Pediatr. 2016;179:263–5.

    Article  CAS  PubMed  Google Scholar 

  65. Dauber A, Cunha-Silva M, Macedo DB, Brito VN, et al. Paternally inherited DLK1 deletion associated with familial central precocious puberty. J Clin Endocrinol Metab. 2017 May 1;102(5):1557–67.

    Article  PubMed  Google Scholar 

  66. Mahachoklertwattana P, Kaplan SL, Grumbach MM. The luteinizing hormone-releasing hormone-secreting hypothalamic hamartoma is a congenital malformation: natural history. J Clin Endocrinol Metab. 1993;77(1):118–24.

    CAS  PubMed  Google Scholar 

  67. Stewart L, Steinbok P, Daaboul J. Role of surgical resection in the treatment of hypothalamic hamartomas causing precocious puberty. Report of six cases. J Neurosurg. 1998;88(2):340–5.

    Article  CAS  PubMed  Google Scholar 

  68. Habiby R, et al. Precocious puberty in children with neurofibromatosis type 1. J Pediatr. 1995;126(3):364–7.

    Article  CAS  PubMed  Google Scholar 

  69. Oberfield SE, et al. Endocrine late effects of childhood cancers. J Pediatr. 1997;131(1 Pt 2):S37–41.

    Article  CAS  PubMed  Google Scholar 

  70. Pescovitz OH, et al. True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog. J Clin Endocrinol Metab. 1984;58(5):857–61.

    Article  CAS  PubMed  Google Scholar 

  71. Soliman AT, et al. Congenital adrenal hyperplasia complicated by central precocious puberty: linear growth during infancy and treatment with gonadotropin-releasing hormone analog. Metabolism. 1997;46(5):513–7.

    Article  CAS  PubMed  Google Scholar 

  72. Foster CM, et al. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome. J Clin Endocrinol Metab. 1984;59(4):801–5.

    Article  CAS  PubMed  Google Scholar 

  73. Holland FJ, Kirsch SE, Selby S. Gonadotropin-independent precocious puberty (“testotoxicosis”); influence of maturational status on response to ketoconazole. J Clin Endocrinol Metab. 1987;64(2):328–33.

    Article  CAS  PubMed  Google Scholar 

  74. Eckert KL, et al. A single-sample, subcutaneous gonadotropin-releasing hormone test for central precocious puberty. Pediatrics. 1996;97(4):517–9.

    CAS  PubMed  Google Scholar 

  75. Rosenfield RL, et al. The rapid ovarian secretory response to pituitary stimulation by the -gonadotropin-releasing hormone agonist nafarelin in sexual precocity. J Clin Endocrinol Metab. 1986;63(6):1386–9.

    Article  CAS  PubMed  Google Scholar 

  76. Ibanez L, et al. Use of leuprolide acetate response patterns in the early diagnosis of pubertal disorders: comparison with the gonadotropin-releasing hormone test. J Clin Endocrinol Metab. 1994;78(1):30–5.

    CAS  PubMed  Google Scholar 

  77. Rosenfield RL, et al. Acute hormonal responses to the gonadotropin releasing hormone agonist leuprolide: dose-response studies and comparison to nafarelin—a clinical research center study. J Clin Endocrinol Metab. 1996;81(9):3408–11.

    CAS  PubMed  Google Scholar 

  78. Boyar RM, et al. Twenty-four hour patterns of plasma luteinizing hormone and follicle-stimulating hormone in sexual precocity. N Engl J Med. 1973;289(6):282–6.

    Article  CAS  PubMed  Google Scholar 

  79. Jakacki RK, Sauder RP, Lloyd SE, et al. Pulsatile secretion of luteinizing hormone in children. J Clin Endocrinol Metab. 1982;55:453–8.

    Article  CAS  PubMed  Google Scholar 

  80. Manasco PU, Muly DM, Godwin SM, et al. Ontogeny of gonadotrophin and inhibin secretion in normal girls through puberty based on overnight serial sampling, and comparison with normal boys. Hum Reprod. 1997;12:2108–14.

    Article  CAS  PubMed  Google Scholar 

  81. Mitamura R, Yano K, Suzuki N, Ito Y, Makita Y, Okuno A. Diurnal rhythms of luteinizing hormone, follicle-stimulating hormone, and testosterone secretion before the onset of male puberty. J Clin Endocrinol Metab. 1999;84:29–37.

    CAS  PubMed  Google Scholar 

  82. FB W, Kelnar GE, Stirling CJH, Huhtaniemi HF. Patterns of pulsatile luteinizing and follicle-stimulating hormone secretion in prepubertal (midchildhood) boys and girls and patients with idiopathic hypogonadotropic hypogonadism (Kallmann’s syndrome): a study using an ultrasensitive time-resolved immunofluorometric assay. J Clin Endocrinol Metab. 1991;72:1229–37.

    Article  Google Scholar 

  83. Hall DA, et al. Sonographic monitoring of LHRH analogue therapy in idiopathic precocious puberty in young girls. J Clin Ultrasound. 1986;14(5):331–8.

    Article  CAS  PubMed  Google Scholar 

  84. Fuld K, Chi C, Neely EK. A randomized trial of 1- and 3-month depot leuprolide doses in the treatment of central precocious puberty. J Pediatr. 2011;159:982–987.e1.

    Article  CAS  PubMed  Google Scholar 

  85. Lee PA, Klein K, Mauras N, Neely EK, Bloch CA, Larsen L, Mattia-Goldberg C, Chwalisz K. Efficacy and safety of leuprolide acetate 3-month depot 11.25 milligrams or 30 milligrams for the treatment of central precocious puberty. J Clin Endocrinol Metab. 2012;97:1572–80.

    Article  CAS  PubMed  Google Scholar 

  86. Mericq V, Lammoglia JJ, Unanue N, Villaroel C, Hernández MI, Avila A, Iñiguez G, Klein KO. Comparison of three doses of leuprolide acetate in the treatment of central precocious puberty: preliminary results. Clin Endocrinol (Oxf). 2009;71:686–90.

    Article  CAS  Google Scholar 

  87. Rahhal S, Clarke WL, Kletter GB, Lee PA, Neely EK, Reiter EO, Saenger P, Shulman D, Silverman L, Eugster EA. Results of a second year of therapy with the 12-month histrelin implant for the treatment of central precocious puberty. Int J Pediatr Endocrinol. 2009;2009:812517.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Lewis KA, Eugster EA. Continual suppression by the histrelin implant for the treatment of central precocious puberty when left in place for two years. In: Proceedings from the Annual Meeting of the Pediatric Academic Societies and Asian Society for Pediatric Research; May 2, 2011; Denver, CO; Abstract 3285.1.

    Google Scholar 

  89. Cavallo A, et al. A simplified gonadotrophin-releasing hormone test for precocious puberty. Clin Endocrinol (Oxf). 1995;42(6):641–6.

    Article  CAS  Google Scholar 

  90. Oerter KE, et al. Effects of luteinizing hormone-releasing hormone agonists on final height in luteinizing hormone-releasing hormone-dependent precocious puberty. Acta Paediatr Suppl. 1993;388:62–8. discussion 69

    CAS  PubMed  Google Scholar 

  91. Oostdijk W, et al. Final height in central precocious: puberty after long term treatment with a slow release GnRH agonist. Arch Dis Child. 1996;75(4):292–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Oerter KE, et al. Adult height in precocious puberty after long-term treatment with deslorelin. J Clin Endocrinol Metab. 1991;73(6):1235–40.

    Article  CAS  PubMed  Google Scholar 

  93. Bar A, et al. Bayley-Pinneau method of height prediction in girls with central precocious puberty: correlation with adult height. J Pediatr. 1995;126(6):955–8.

    Article  CAS  PubMed  Google Scholar 

  94. Pasquino AM, et al. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty. J Clin Endocrinol Metab. 1996;81(3):948–51.

    CAS  PubMed  Google Scholar 

  95. Saggese G, et al. Effect of combined treatment with gonadotropin releasing hormone analogue and growth hormone in patients with central precocious puberty who had subnormal growth velocity and impaired height prognosis. Acta Paediatr. 1995;84(3):299–304.

    Article  CAS  PubMed  Google Scholar 

  96. Walvoord EC, Pescovitz OH. Combined use of growth hormone and gonadotropin-releasing hormone analogues in precocious puberty: theoretic and practical considerations. Pediatrics. 1999;104(4 Pt 2):1010–4.

    CAS  PubMed  Google Scholar 

  97. Pasquino AM, Pucarelli I, Segni M, Matrunola M, Cerroni F. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone, analogues and growth hormone. J Clin Endocrinol Metab. 1999;84:449–52.

    Article  CAS  PubMed  Google Scholar 

  98. Neely EK, et al. Bone mineral density during treatment of central precocious puberty. J Pediatr. 1995;127(5):819–22.

    Article  CAS  PubMed  Google Scholar 

  99. Bertelloni S, et al. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females. Eur J Pediatr. 1998;157(5):363–7.

    Article  CAS  PubMed  Google Scholar 

  100. Lazar L, et al. Early polycystic ovary-like syndrome in girls with central precocious puberty and exaggerated adrenal response. Eur J Endocrinol. 1995;133(4):403–6.

    Article  CAS  PubMed  Google Scholar 

  101. Jay N, et al. Ovulation and menstrual function of adolescent girls with central precocious puberty after therapy with gonadotropin-releasing hormone agonists. J Clin Endocrinol Metab. 1992;75(3):890–4.

    CAS  PubMed  Google Scholar 

  102. Saenz CA, et al. Premature thelarche and ovarian cyst probably secondary to estrogen contamination. Bol Asoc Med P R. 1982;74(2):16–9.

    CAS  PubMed  Google Scholar 

  103. Saenz de Rodriguez CA, Toro-Sola MA. Anabolic steroids in meat and rema premature thelarche. Lancet. 1982;1(8284):1300.

    Article  CAS  PubMed  Google Scholar 

  104. Saenz de Rodriguez CA, Bongiovanni AM, Conde de Borrego L. An epidemic of precocious development in Puerto Rican children. J Pediatr. 1985;107(3):393–6.

    Article  CAS  PubMed  Google Scholar 

  105. Cohen HE, Eisenberg P, Mandel F, Haller JO. Ovarian cysts are common in premenarchal girls: a sonographic study of 101 children 2–12 yr old. AJR Am J Roentgenol. 1992;159(1):89.

    Article  CAS  PubMed  Google Scholar 

  106. Albright FB, Hampton AM. Syndrome characterized by osteitis fibrosa disseminata, areas of depigmentation and endocrine dysfunction, with precocious puberty in females. N Engl J Med. 1937;216:727.

    Article  Google Scholar 

  107. Weinstein LS, et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med. 1991;325(24):1688–95.

    Article  CAS  PubMed  Google Scholar 

  108. Shenker A, et al. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J Clin Endocrinol Metab. 1994;79(3):750–5.

    CAS  PubMed  Google Scholar 

  109. Shenker A, et al. Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS. J Pediatr. 1993;123(4):509–18.

    Article  CAS  PubMed  Google Scholar 

  110. Pienkowski C, et al. Recurrent ovarian cyst and mutation of the Gs alpha gene in ovarian cyst fluid cells: what is the link with McCune-Albright syndrome? Acta Paediatr. 1997;86(9):1019–21.

    Article  CAS  PubMed  Google Scholar 

  111. DiMeglio LA, Pescovitz OH. Disorders of puberty: inactivating and activating molecular mutations. J Pediatr. 1997;131(1 Pt 2):S8–12.

    CAS  PubMed  Google Scholar 

  112. Mastorakos G, et al. Hyperthyroidism in McCune-Albright syndrome with a review of thyroid abnormalities sixty yr after the first report. Thyroid. 1997;7(3):433–9.

    Article  CAS  PubMed  Google Scholar 

  113. Cavanah SF, Dons RF. McCune-Albright syndrome: how many endocrinopathies can one patient have? South Med J. 1993;86(3):34–7.

    Article  Google Scholar 

  114. Lee PA, Van Dop C, Migeon CJ. McCune-Albright syndrome. Long-term follow-up. JAMA. 1986;256(21):2980–4.

    Article  CAS  PubMed  Google Scholar 

  115. Holland FJ. Gonadotropin-independent precocious puberty. Endocrinol Metab Clin North Am. 1991;20(1):191–210.

    CAS  PubMed  Google Scholar 

  116. Benedict PH. Sex precocity and polyostotic fibrous dysplasia. Report of a case in a boy with testicular biopsy. Am J Dis Child. 1966;111(4):426–9.

    Article  CAS  PubMed  Google Scholar 

  117. Foster CM, et al. Ovarian function in girls with McCune-Albright syndrome. Pediatr Res. 1986;20(9):859–63.

    Article  CAS  PubMed  Google Scholar 

  118. Schmidt H, Kiess W. Secondary central precocious puberty in a girl with McCune-Albright syndrome responds to treatment with GnRH analogue. J Pediatr Endocrinol Metab. 1998;11(1):77–81.

    Article  CAS  PubMed  Google Scholar 

  119. Sorgo W, et al. The effects of cyproterone acetate on statural growth in children with precocious puberty. Acta Endocrinol. 1987;115(1):44–56.

    CAS  PubMed  Google Scholar 

  120. Feuillan PP, et al. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone. N Engl J Med. 1986;315(18):1115–9.

    Article  CAS  PubMed  Google Scholar 

  121. Feuillan PP, Jones J, Cutler GB Jr. Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright, syndrome. J Clin Endocrinol Metab. 1993;77(3):647–51.

    CAS  PubMed  Google Scholar 

  122. Feuillan P, Calis K, Hill S, Shawker T, Robey PG, Collins MT. Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome: a pilot study. J Clin Endocrinol Metab. 2007;92:2100–6.

    Article  CAS  PubMed  Google Scholar 

  123. Eugster EA, et al. Tamoxifen treatment of progressive precocious puberty in a patient with McCune-Albright, syndrome. J Pediatr Endocrinol Metab. 1999;12(5):681–6.

    Article  CAS  PubMed  Google Scholar 

  124. Sims EK, Garnett S, Guzman F, Paris F, Sultan C, Eugster EA, Fulvestrant McCune-Albright study group. Fulvestrant treatment of precocious puberty in girls with McCune-Albright syndrome. Int J Pediatr Endocrinol. 2012;2012:26.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  125. Lala R, Andreo M, Pucci A, Matarazzo P. Persistent hyperestrogenism after precocious puberty in young females with McCune-Albright syndrome. Pediatr Endocrinol Rev. 2007;4(Suppl 4):423–8.

    PubMed  Google Scholar 

  126. Shenker A, et al. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty [see comments]. Nature. 1993;365(6447):652–4.

    Article  CAS  PubMed  Google Scholar 

  127. Kremer H, et al. Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty. Hum Mol Genet. 1993;2(11):1779–83.

    Article  CAS  PubMed  Google Scholar 

  128. Kraaij R, et al. A missense mutation in the second transmembrane segment of the luteinizing hormone receptor causes familial male-limited precocious puberty. J Clin Endocrinol Metab. 1995;80(11):3168–72.

    CAS  PubMed  Google Scholar 

  129. Gromoll J, et al. A mutation in the first transmembrane domain of the lutropin receptor causes male precocious puberty. J Clin Endocrinol Metab. 1998;83(2):476–80.

    Article  CAS  PubMed  Google Scholar 

  130. Laue L, et al. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. Proc Natl Acad Sci U S A. 1995;92(6):1906–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  131. Latronico AC, et al. A unique constitutively activating mutation in third transmembrane helix of luteinizing hormone receptor causes sporadic male gonadotropin-independent precocious puberty. J Clin Endocrinol Metab. 1998;83(7):2435–40.

    CAS  PubMed  Google Scholar 

  132. Schedewie HK, et al. Testicular leydig cell hyperplasia as a cause of familial sexual precocity. J Clin Endocrinol Metab. 1981;52(2):271–8.

    Article  CAS  PubMed  Google Scholar 

  133. Clark PA, Clarke WL. Testotoxicosis. An unusual presentation and novel gene mutation. Clin Pediatr (Phila). 1995;34(5):271–4.

    Article  CAS  Google Scholar 

  134. Reiter EO, et al. Male-limited familial precocious puberty in three generations. Apparent Leydig-cell autonomy and elevated glycoprotein hormone alpha subunit. N Engl J Med. 1984;311(8):515–9.

    Article  CAS  PubMed  Google Scholar 

  135. Egli CA, et al. Pituitary gonadotropin-independent male-limited autosomal dominant sexual precocity in nine generations: familial testotoxicosis. J Pediatr. 1985;106(1):33–40.

    Article  CAS  PubMed  Google Scholar 

  136. Kawate N. Identification of constitutively activating mutation of the luteinising hormone receptor in a family with male limited gonadotrophin independent precocious puberty (testotoxicosis). J Med Genet. 1995;32(7):553–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  137. Rosenthal SM, Grumbach MM, Kaplan SL. Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases. J Clin Endocrinol Metab. 1983;57(3):571–9. 119

    Article  CAS  PubMed  Google Scholar 

  138. Holland FJ, et al. Ketoconazole in the management of precocious puberty not responsive to LHRH-analogue therapy. N Engl J Med. 1985;312(16):1023–8.

    Article  CAS  PubMed  Google Scholar 

  139. Laue L, et al. Treatment of familial male precocious puberty with spironolactone and testolactone. N Engl J Med. 1989;320(8):496–502.

    Article  CAS  PubMed  Google Scholar 

  140. Babovic-Vuksanovic D, et al. Hazards of ketoconazole therapy in testotoxicosis. Acta Paediatr. 1994;83(9):994–7.

    Article  CAS  PubMed  Google Scholar 

  141. Reiter EO, Mauras N, McCormick K, Kulshreshtha B, et al. Bicalutamide plus anastrozole for the treatment of gonadotropin-independent precocious puberty in boys with testotoxicosis: a phase II, open-label pilot study (BATT). J Pediatr Endocrinol Metab. 2010;23:999–1009.

    Article  CAS  PubMed  Google Scholar 

  142. Lenz AM, Shulman D, Eugster EA, Rahhal S, Fuqua JS, Pescovitz OH, Lewis KA. Bicalutamide and third-generation aromatase inhibitors in testotoxicosis. Pediatrics. 2010;126:e728–33.

    Article  PubMed  PubMed Central  Google Scholar 

  143. Laue L, et al. Treatment of familial male precocious puberty with spironolactone, testolactone, and deslorelin. J Clin Endocrinol Metab. 1993;76(1):151–5.

    CAS  PubMed  Google Scholar 

  144. Skinner MA, et al. Ovarian neoplasms in children. Arch Surg. 1993;128(8):849–53. discussion 853–4

    Article  CAS  PubMed  Google Scholar 

  145. Bouffet E, et al. Juvenile granulosa cell tumor of the ovary in infants: a clinicopathologic study of three cases and review of the literature. J Pediatr Surg. 1997;32(5):762–5.

    Article  CAS  PubMed  Google Scholar 

  146. Nakashima N, Young RH, Scully RE. Androgenic granulosa cell tumors of the ovary. A clinicopathologic analysis of 17 cases and review of the literature. Arch Pathol Lab Med. 1984;108(10):786–91.

    CAS  PubMed  Google Scholar 

  147. Cronje HS, et al. Granulosa and theca cell tumors in children: a report of 17 cases and literature review. Obstet Gynecol Surv. 1998;53(4):240–7.

    Article  CAS  PubMed  Google Scholar 

  148. Bas F, Pescovitz OH, Steinmetz R. No activating mutations of FSH receptor in four children with ovarian juvenile granulosa cell tumors and the association of these tumors with central precocious puberty. J Pediatr Adolesc Gynecol. 2009;22(3):173–9.

    Article  PubMed  Google Scholar 

  149. Masur Y, et al. Leydig cell tumors of the testis—clinical and morphologic aspects. Urologe A. 1996;35(6):468–71.

    Article  CAS  PubMed  Google Scholar 

  150. Diamond FB Jr, et al. Hetero- and isosexual pseudoprecocity associated with testicular sex-cord tumors in an 8 year-old male. J Pediatr Endocrinol Metab. 1996;9(3):407–14.

    Article  PubMed  Google Scholar 

  151. Kim I, Young RH, Scully RE. Leydig cell tumors of the testis. A clinicopathological analysis of 40 cases and review of the literature. Am J Surg Pathol. 1985;9(3):177–92.

    Article  CAS  PubMed  Google Scholar 

  152. Comite F, et al. Isosexual precocious pseudopuberty secondary to a feminizing adrenal tumor. J Clin Endocrinol Metab. 1984;58(3):435–40.

    Article  CAS  PubMed  Google Scholar 

  153. Heimann A, et al. Hepatoblastoma presenting as isosexual precocity. The clinical importance of histologic and serologic parameters. J Clin Gastroenterol. 1987;9(1):105–10.

    Article  CAS  PubMed  Google Scholar 

  154. Otsuka T, et al. Primary pulmonary choriocarcinoma in a four month old boy complicated with precocious puberty. Acta Paediatr Jpn. 1994;36(4):404–7.

    Article  CAS  PubMed  Google Scholar 

  155. Derenoncount AN, Castro-Magana M, Jones KL. Mediastinal teratoma and precocious puberty in a boy with mosaic Klinefelter syndrome. Am J Med Genet. 1995;55(1):38–42. 135

    Article  Google Scholar 

  156. Cohen AR, Wilson JA, Sadeghi-Nejad A. Gonadotropin-secreting pineal teratoma causing precocious puberty. Neurosurgery. 1991;28(4):597–602. discussion 602–3, 136.

    Article  CAS  PubMed  Google Scholar 

  157. Tamaki N, et al. Germ cell tumors of the thalamus and the basal ganglia. Childs Nerv Syst. 1990;6(1):3–7. 137

    Article  CAS  PubMed  Google Scholar 

  158. Kukuvitis A, Matte C, Polychronakos C. Central precocious puberty following feminizing right ovarian granulosa cell tumor. Horm Res. 1995;44(6):268–70.

    Article  CAS  PubMed  Google Scholar 

  159. Leschek EW, et al. Localization by venous sampling of occult chorionic gonadotropin-secreting tumor in a boy with mosaic Klinefelter’s syndrome and precocious puberty. J Clin Endocrinol Metab. 1996;81(11):3825–8.

    CAS  PubMed  Google Scholar 

  160. Englund AT, et al. Pediatric germ cell and human chorionic gonadotropin-producing tumors. Clinical and laboratory features. Am J Dis Child. 1991;145(11):1294–7.

    Article  CAS  PubMed  Google Scholar 

  161. Hasle H, et al. Mediastinal germ cell tumour associated with Klinefelter syndrome. A report of case and review of the literature. Eur J Pediatr. 1992;151(10):735–9.

    Article  CAS  PubMed  Google Scholar 

  162. Van Wyk JG. Syndrome of precocious menstruation and galactorrhea in juvenile hypothyroidism: an example of hormonal overlap in pituitary feedback. J Pediatr. 1960;57:416.

    Article  Google Scholar 

  163. Lindsay AV, MacGillivray ML. Multicystic ovaries detected by sonography. Am J Dis Child. 1980;134:588–92.

    CAS  PubMed  Google Scholar 

  164. Bruder JS, Bremner MH, Ridgway WJ, Wierman EC. Hypothyroidism-induced macroorchidism: use of a gonadotropin-releasing agonist to understand its mechanism and augment adult stature. J Clin Endocrinol Metab. 1995;80:11–6.

    CAS  PubMed  Google Scholar 

  165. Anasti JN, et al. A potential novel mechanism for precocious puberty in juvenile hypothyroidism. J Clin Endocrinol Metab. 1995;80(1):276–9.

    CAS  PubMed  Google Scholar 

  166. Desforges J. Gynecomastia. N Engl J Med. 1993;328(7):490.

    Article  Google Scholar 

  167. Coen P. An aromatase-producing sex-cord tumor resulting in prepubertal gynecomastia. N Engl J Med. 1991;324(5):317.

    Article  CAS  PubMed  Google Scholar 

  168. Halperin DS, Sizonenko PC. Prepubertal gynecomastia following topical inunction of estrogen containing ointment. Helv Paediatr Acta. 1983;38(4):361–6.

    CAS  PubMed  Google Scholar 

  169. Edidin DL. Prepubertal gynecomastia associated with estrogen-containing hair cream. Am J Dis Child. 1982;136(7):587.

    CAS  PubMed  Google Scholar 

  170. Latorre HK. Idiopathic gynecomastia in seven preadolescent boys. Am J Dis Child. 1973;126:771.

    Article  CAS  PubMed  Google Scholar 

  171. Stratakis CA, et al. The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription. J Clin Endocrinol Metab. 1998;83(4):1348–57.

    CAS  PubMed  Google Scholar 

  172. Fontoura M, et al. Precocious puberty in girls: early diagnosis of a slowly progressing variant. Arch Dis Child. 1989;64(8):1170–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  173. Kreiter M, et al. Preserving adult height potential in girls with idiopathic true precocious puberty. J Pediatr. 1990;117(3):364–70.

    Article  CAS  PubMed  Google Scholar 

  174. Bassi F, et al. Precocious puberty: auxological criteria discriminating different forms. J Endocrinol Invest. 1994;17(10):793–7.

    Article  CAS  PubMed  Google Scholar 

  175. Leger J, Reynaud R, Czernichow P. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment? J Pediatr. 2000;137(6):819–25.

    Article  CAS  PubMed  Google Scholar 

  176. Brauner R, et al. Adult height in girls with idiopathic true precocious puberty. J Clin Endocrinol Metab. 1994;9(2):415–20.

    Google Scholar 

  177. Ghirri P, et al. Final height in girls with slowly progressive untreated central precocious puberty. Gynecol Endocrinol. 1997;11(5):301–5.

    Article  CAS  PubMed  Google Scholar 

  178. Brito VN, Batista MC, Borges MF, Latronico AC, Kohek MB, Thirone AC, Jorge BH, Arnhold IJ, Mendonca BB. Diagnostic value of fluorometric assays in the evaluation of precocious puberty. J Clin Endocrinol Metab. 1999;84(10):3539–44.

    CAS  PubMed  Google Scholar 

  179. Tanner JM. Growth at adolescence. Oxford: Blackwell Scientific Publications; 1962. p. 30–6.

    Google Scholar 

  180. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440.

    Article  CAS  PubMed  Google Scholar 

  181. Eugster EA, Pescovitz OH. Precocious puberty. In: DeGroot LJ, editor. Endocrinology. 4th ed: Elsevier Health Science Books. Philadelphia: PA; 2001. p. 2011–21.

    Google Scholar 

Download references

Acknowledgment

The editors wish to thank Henry Rodriguez MD and Grace C. Dougan MD for their contributions to this chapter in the prior edition.

Author information

Authors and Affiliations

  1. Pediatric Endocrinology, Massachusetts General Hospital for Children, Boston, MA, USA

    Madhusmita Misra MD, MPH

  2. Pediatrics, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA

    Sally Radovick MD

Authors
  1. Madhusmita Misra MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sally Radovick MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Madhusmita Misra MD, MPH .

Editor information

Editors and Affiliations

  1. Department of Pediatrics, Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA

    Sally Radovick

  2. Pediatric Endocrinology, Massachusetts General Hospital for Children, Boston, Massachusetts, USA

    Madhusmita Misra

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Misra, M., Radovick, S. (2018). Precocious Puberty. In: Radovick, S., Misra, M. (eds) Pediatric Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-319-73782-9_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-73782-9_26

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-73781-2

  • Online ISBN: 978-3-319-73782-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation